title: Intravenous magnesium sulfate for acute termination of sustained monomorphic ventricular tachycardia associated with coronary artery disease.
abstract: The efficacy of intravenous magnesium in terminating sustained monomorphic ventricular tachycardia was examined in this study. This therapy was found to be ineffective in aborting monomorphic ventricular tachycardia induced in the electrophysiology laboratory.
authors.affiliation: The Department of Cardiology, Royal Adelaide Hospital, Australia.
authors.forename: H M
authors.initials: HM
authors.lastname: Farouque
authors.forename: P
authors.initials: P
authors.lastname: Sanders
authors.forename: G D
authors.initials: GD
authors.lastname: Young
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D003327:Coronary Disease / Q000150:complications* / Q000503:physiopathology; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007262:Infusions, Intravenous; D008278:Magnesium Sulfate / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D017180:Tachycardia, Ventricular / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D008278:Magnesium Sulfate